Skip to main content
Premium Trial:

Request an Annual Quote

Robert Negm, David Weber, Iuliana Lazar


Robert Negm has become the new vice president of business development at GenTel BioSurfaces. Prior to joining GenTel, Negm was director of business development at Whatman, Schleicher & Schuell for about two years. Prior to that, he was a program director at the National Cancer Institute for two years.

Stratagene said last week that David Weber is the company's new senior vice president of marketing, and will lead Stratagene's global marketing programs for its life sciences division. Weber most recently served as president of the Americas region for GE Healthcare. Prior to this, he was vice president of marketing and sales support for Amersham Pharmacia Biotech, which was acquired by GE Healthcare early last year. He has also served as vice president of direct marketing and customer care for Pharmacia Biotech, and vice president of marketing and supplier relations at Chemdex. Weber holds a BS in biochemistry from Rutgers University.

Iuliana Lazar, a research assistant professor at the Virginia Bioinformatics Institute at Virginia Polytechnic Institute, this week was awarded a five-year, $400,000 National Science Foundation Faculty Early Career Development Award for research on the development for microfluidic devices with mass spectrometric detection for proteomic applications.

This research will lead to the development of unique micro-analytical systems and detection strategies that can be used in the areas of biomedical research, medicine, agriculture, biodefense, and other areas that benefit from proteomic investigations, according to Virginia Tech.

The long-term objective of Lazar's project is the development of microfluidic platforms with mass spectrometric detection for bioanalytical applications. Three areas of research will be examined: microfluidic platform development, microchip-mass spectrometric interface development, and bioanalytical process implementation on the chip.

Lazar received her PhD in chemistry at Brigham Young University in 1997. Before joining VBI in 2003, she spent two years as a postdoctoral fellow at Oak Ridge National Laboratory, and three years as a principal research scientist at the Barnett Institute at Northeastern University.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.